Table 1

Demographic and clinical characteristics of all patients (N=250).

Variablesn (%)
Age (years)72.3±11.8 (35-97)
Gender
 Female124(49.6)
 Male126(50.4)
Co-morbidity
 Hypertension185(74.0)
 Coronary artery disease100(40.0)
 Diabetes mellitus 74(29.6)
 Cardiac heart failure 42(16.8)
 Hyperlipidemia 39(15.6)
 Chronic obstructive pulmonary disease 25(10.0)
 Other138(55.2)
 Smoking 73(29.2)
Latency 8(2-120)
TOAST
 Large artery disease 22 (8.8)
 Cardioembolism 29(11.6)
 Small artery disease (lacune) 40(16.0)
 Stroke of other determined0-
 Stroke of undetermined159(63.6)
mRS
 No significant disability 46(18.4)
 Slight disability 86(34.4)
 Moderate disability 49(19.6)
 Moderate-severe disability 20 (8.0)
 Severe disability 13 (5.2)
 Dead 36(14.4)
NIHSS 6(1-18)
Latency (mean)(h)13.77±17.14 (2-120)
Hospitalization days 4(1-116)
TIV(h)4.0±9.2 (0-65 hours)
MPV (mean)8.7 (4.4-15.7)
  • SD - standard deviation, min - minimum, max - maximum, TOAST - The Trial Of Org 10172 in Acute Stroke Treatment, mRS - modified Rankin scale, NIHSS - National Institutes of Health Stroke Scale, TIV - time interval of venipuncture, MPV - mean platelet volume